These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24878382)

  • 1. The antihypertensive effects of sodium nitrite are not associated with circulating angiotensin converting enzyme inhibition.
    Pinheiro LC; Amaral JH; Ferreira GC; Montenegro MF; Oliveira-Paula GH; Tanus-Santos JE
    Nitric Oxide; 2014 Aug; 40():52-9. PubMed ID: 24878382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
    Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active-site directed peptide l-Phe-d-His-l-Leu inhibits angiotensin converting enzyme activity and dexamethasone-induced hypertension in rats.
    Savitha MN; Siddesha JM; Suvilesh KN; Yariswamy M; Vivek HK; D'Souza CJM; Umashankar M; Vishwanath BS
    Peptides; 2019 Feb; 112():34-42. PubMed ID: 30481537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEMPOL enhances the antihypertensive effects of sodium nitrite by mechanisms facilitating nitrite-derived gastric nitric oxide formation.
    Amaral JH; Montenegro MF; Pinheiro LC; Ferreira GC; Barroso RP; Costa-Filho AJ; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():446-455. PubMed ID: 23892053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase 2 partly mediates hypotensive effect of nitrite on L-NAME-induced hypertension in normoxic rat.
    Sonoda K; Ohtake K; Kubo Y; Uchida H; Uchida M; Natsume H; Kobayashi M; Kobayashi J
    Clin Exp Hypertens; 2014; 36(6):410-8. PubMed ID: 24164360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension.
    Montenegro MF; Amaral JH; Pinheiro LC; Sakamoto EK; Ferreira GC; Reis RI; Marçal DM; Pereira RP; Tanus-Santos JE
    Free Radic Biol Med; 2011 Jul; 51(1):144-52. PubMed ID: 21530643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial inhibition of Angiotensin converting enzyme, Neutral endopeptidase and Aminopeptidase N by N-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension.
    Savitha MN; Suvilesh KN; Siddesha JM; Milan Gowda MD; Choudhury M; Velmurugan D; Umashankar M; Vishwanath BS
    Peptides; 2020 Jan; 123():170180. PubMed ID: 31715212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.
    Seth MK; Hussain ME; Pasha S; Fahim M
    Drug Des Devel Ther; 2016; 10():1533-42. PubMed ID: 27143859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat.
    Ruiz-Giménez P; Marcos JF; Torregrosa G; Lahoz A; Fernández-Musoles R; Valles S; Alborch E; Manzanares P; Salom JB
    Peptides; 2011 Jul; 32(7):1431-8. PubMed ID: 21605609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular angiotensin converting enzyme is responsible for nitro-L-arginine methyl ester (L-NAME)-induced salt sensitivity.
    Giani JF; Eriguchi M; Bernstein EA; Katsumata M; Shen XZ; Li L; McDonough AA; Fuchs S; Bernstein KE; Gonzalez-Villalobos RA
    Kidney Int; 2017 Apr; 91(4):856-867. PubMed ID: 27988209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme.
    Gasparotto Junior A; Gasparotto FM; Lourenço EL; Crestani S; Stefanello ME; Salvador MJ; da Silva-Santos JE; Marques MC; Kassuya CA
    J Ethnopharmacol; 2011 Mar; 134(2):363-72. PubMed ID: 21185932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension.
    Sharma DK; Manral A; Saini V; Singh A; Srinivasan BP; Tiwari M
    Eur J Pharmacol; 2012 Sep; 691(1-3):198-208. PubMed ID: 22819707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Nitrite Prevents both Reductions in Circulating Nitric Oxide and Hypertension in 7-Day Lead-Treated Rats.
    Gonçalves-Rizzi VH; Nascimento RA; Possomato-Vieira JS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):225-30. PubMed ID: 26333850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant food-derived Angiotensin I converting enzyme inhibitory peptides.
    Guang C; Phillips RD
    J Agric Food Chem; 2009 Jun; 57(12):5113-20. PubMed ID: 19449887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.